PATENT CLAIM ANALYSIS

Application Number: 16251318
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "364000"]

Abstract:
Provided herein are pharmaceutical compositions, which comprise a 1,2,4-oxadiazole benzoic acid or a pharmaceutically acceptable salt thereof. Further provided herein are certain pharmaceutically acceptable salts of a 1,2,4-oxadiazole benzoic acid and methods for making the same. Further provided herein are methods of treating or preventing a disease associated with a nonsense mutation or a premature stop codon, comprising administering such pharmaceutical compositions or pharmaceutically acceptable salts to a patient having a disease associated with a nonsense mutation or a premature stop codon.

Claim (Index 5):
A method for treating, preventing or managing an ocular disease associated with a nonsense mutation or a premature stop codon, comprising administering an effective amount of a salt form of  claim 1  to a patient having an ocular disease associated with a nonsense mutation or a premature stop codon.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 99.0
- Lexical Diversity: 1.93333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15123309', '15838478', '15771379', '11918114', '15291173']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7803674234539366
- 35 USC 102 Novelty (BERT): 0.6532303750575599
- Combined Prediction Score: 0.767653718614299
- Mean Citation Score: 382.903596
- Max Citation Score: 628.6744
- Similarity Product: 593.1276802491665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test